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Bone marrow mesenchymal stem cells (BMMSCs) may serve as an alternative source to 
terminally differentiated cells for tissue engineering applications.  Our group has demonstrated 
that BMMSCs subjected to a mechanical environment may differentiate toward a smooth muscle 
cell (SMC) phenotype.  Growth factors in conjunction with mechanical stimulation have been 
shown in prior work to have a significant effect in regulating SMC phenotype in 2D.  
Simultaneous stimulation with mechanical strain and TGF-β has been shown to increase α-actin 
expression in SMCs when compared to mechanical strain alone.  Taken together, this previous 
work suggests that mechanical and chemical factors may work together to promote 
differentiation of BMMSCs toward an SMC phenotype.  Consequently, the hypothesis of the 
current work is that uniaxial cyclic strain and biochemical stimulation with TGF-β will 
differentiate BMMSCs towards an SMC-like lineage in a synergistic manner in 3D. 
 To evaluate this hypothesis, rat BMMSCs suspended in a fibrin gel were subjected to 
cyclic mechanical strains and frequencies physiologically consistent with the arterial system, in 
combination with chemical stimulation with TGF-β.  Changes in morphology, proliferation, 
collagen production, and qualitative protein expression were assessed to determine if there were 
any synergistic effects between mechanical and chemical stimulation.   
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 Results revealed that BMMSCs subjected to both mechanical and biochemical 
stimulation led to an increase in production of contractile machinery intrinsic to terminally-
differentiated SMCs, an increase in expression of SMC marker proteins, and an increase in 
collagen production when compared to control groups.  These results support our hypothesis and 
suggest that combined mechanical and biochemical stimulation may be important in stem cell-
based regenerative medicine applications involving SMCs.    
Future work will evaluate SMC gene expression and functionality to better define the role 
of mechanical and biochemical stimuli in differentiating BMMSCs toward a terminally 
differentiated SMC phenotype. 
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1.0  INTRODUCTION 
1.1 POTENTIAL TARGETS FOR SMOOTH MUSCLE CELL-BASED 
REGENERATIVE MEDICINE 
Smooth muscle cells (SMCs) are components of the excretory, respiratory, digestive, and 
vascular systems, all of which are susceptible to disease and dysfunction. Regenerative medicine 
and tissue engineering allows tissue and organ scientists to create biological substitutes for 
various diseases and conditions affecting the urethra, bladder, esophagus, trachea, colon and 
blood vessels, to name a few.  When creating a biological substitute for these tissues and organs, 
there is an inherent need for SMCs.  These organ systems in the body rely on a smooth muscle 
layer to functionally maintain the mechanical strength of the tissue.  The limitations of using 
terminally differentiated cells in regenerative medicine may be inhibiting progress, as telomere 
shortening during cell replication may be associated with senescence of the cell [1, 2].   
1.1.1 Urinary Tract Disorders 
1.1.1.1 Urethra  
Stress urinary incontinence is the involuntary loss of urine due to sudden increases in abdominal 
pressure. Acellular matrices, such as polyglycolic acid (PGA) and collagen-based substrates 
from the small intestine and bladder, have been utilized in animal models in an effort to 
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regenerate urethral tissue [3, 4]. These acellular matrices have been used clinically to treat 
patients with hypospadias and urethral stricture disease.  The inherent off-the-shelf availability of 
the matrices is also ideal because of the decreased surgical time while eliminating the concern 
for donor site morbidity.  Autologous cells have been utilized to create a cellular component 
using the same collagen matrices for urethral reconstruction [5].  As SMCs are an integral 
component to the native urethral architecture, there is a need to for this cell type in urethral tissue 
engineering applications.  Researchers have shown that bladder cells seeded onto collagen 
matrices derived from bladder submucosa reveal differentiation toward an SMC phenotype via 
qualitative and quantitative protein analysis [5]. 
1.1.1.2 Bladder 
Spina bifida, a common birth defect where the embryonic neural tube fails to close completely, 
leads to poor or absent bladder control later in life.  Patients with this disease have been treated 
with catheterization and pharmacotherapy to promote urinary continence.  Bladder augmentation 
is often achieved by replacing segments of the bladder using stomach or intestinal segments.  
While functionally this has been proven to be successful, there are several complications 
associated with this reconstruction, primarily involving the inability to void urine.  A tissue 
engineered approach has therefore been sought out to alleviate the complications due to these 
augmentation procedures.  Researchers have created tissue engineered bladder tissue using a 
combined PGA-collagen scaffold seeded with autologous urothelial and smooth muscle cells.  
This was evaluated clinically for the first time in 1999 [6].  Patients receiving the PGA-collagen 
scaffold for reconstruction showed increased compliance, increased capacity and longer dry 
periods [7].  However, the use of undifferentiated cells may prove to be more successful for 
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tissue engineered bladder applications, as mesenchymal stem cells have been shown to migrate 
to the bladder graft location and differentiate into SMCs [8]. 
1.1.2 Respiratory Disease 
A clinically successful tracheal transplantation is still in the distant future, and efforts are still 
underway to create a tissue engineered trachea to treat congential defects such as stenosis, 
agenesis and atresia. While a rigid hyaline cartilage component is one the major requirements for 
a functional tissue-engineered trachea, SMCs are required to generate a muscular tube while 
promoting a vascular network [9].  Researchers have used bone marrow progenitor cells seeded 
onto decellularized small bowel submucosa.  Under laminar flow perfusion, these cells were 
shown to differentiate to SMCs and were oriented longitudinally along matrix fibers [9].  For this 
application, functional SMCs are necessary to respond to mechanical stresses intrinsic to normal 
breathing to maintain normal contractile function, where loss of functionality may lead to 
ischemic injury. This work also demonstrates the possible role of mechanical forces in 
differentiating bone marrow-derived progenitor cells toward an SMC lineage.   
1.1.3 Cardiovascular Disease 
Cardiovascular disease is the leading cause of death in the United States, with an estimated one 
in three American adults having one or more types of cardiovascular disease (CVD).  Care and 
treatment of those with CVD in the US will cost nearly 450 billion in 2008 [10].  Coronary artery 
disease is the most deadly form of CVD, where the blood supply to the heart is compromised due 
to an obstruction in the coronary arteries, often leading to myocardial infarction as a result of 
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oxygen deprivation.  Coronary artery disease will often require surgery, with nearly 500,000 
inpatient bypass procedures in 2005 [10].  Bypass surgery generally involves multiple vascular 
grafts, as the patient’s internal mammary artery or saphenous vein is often utilized as an 
autologous vessel replacement.  Although an autologous vessel is desired, there are many 
patients whose native vessels are unavailable for use either from being diseased themselves or 
due to being already used during a prior surgery.  Moreover, these autologous grafts tend to fail 
within 10 years [11].  Synthetic grafting has also been prone to failure due to calcification, 
ingrowth of smooth muscle cells (SMCs) and thrombus formation [12, 13].  Clearly there is a 
need for an alternative small-diameter vessel substitute [14-16].  Tissue-engineered vascular 
grafts (TEVGs) usually involve the incorporation of cells within the scaffold or extracellular 
matrix.  Several cell sources are available for use; however autologous cells are advantageous 
when considering immune rejection [17]. 
Due to the unique architecture and complicated mechanical properties of the vascular 
wall, the ideal tissue engineered vascular graft is still sought after.  Because of this, the Holy 
Grail of vascular tissue engineering has been established; to create a small-diameter blood vessel 
substitute [18]. 
There are several key considerations in designing the ideal vascular substitute, primarily 
involving the mechanical and biological properties.   From a mechanical perspective, a TEVG 
must be able to sustain the mechanical demand intrinsic to the vasculature, i.e. arterial blood 
pressure and flow [19].  Furthermore, the mechanical properties of a TEVG must match that of 
the host vessel, such that there is no compliance mismatch.  A compliance mismatch may 
ultimately lead to intimal hyperplasia at the anastomosis, and in turn, lead to graft failure [20].  
In the biological arena, several key factors come into play, namely the cell source, scaffold 
 5 
material and growth factors.  The primary goal when integrating biological components is to 
create an anti-thrombogenic conduit that exhibits long-term patency, while mimicking the 
complex architecture of a native blood vessel (see Figure 1-1).   
 
Figure 1-1:  Anatomy of a blood vessel [21]. 
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1.1.3.1 Cell sourcing 
Cell sourcing is pivotal in creating a clinically viable TEVG.  Complete functionality of a 
vascular graft may not be accomplished without an endothelialized lumen and contractile SMCs   
[22]. The use of non-autologous or allogenic cell lines may require immunosuppressive 
interventions to avoid host rejection. Therefore, an autologous cell line is advantageous by 
eliminating the concern for immunological rejection.  Autologous cells may be either terminally 
differentiated cells or progenitor cells.   
The use of terminally differentiated cells towards vascular graft applications, such as 
smooth muscle and endothelial cells, offers several advantages.  The main benefit in using these 
cells is that they are of the desired phenotype, and better simulate the cellular constituency of a 
native blood vessel.  However, the use of terminally differentiated cells comes with several 
limitations.  Due to the high cell number required in creating a TEVG, meeting this demand is 
often difficult due to the limited expansion capabilities in vitro.  Telomere shortening during 
DNA replication is the mechanism behind the restricted proliferation potential in vitro.  
Furthermore, terminally differentiated cells are often associated with the same disease pathology 
as the host tissue.  
Progenitor cells have proven to be a valuable alternative to terminally differentiated cells 
in vascular graft applications [23].  Progenitor cells are easily obtainable and expandable, and 
there are several different types being utilized in tissue engineering applications.  These different 
cell types may be found in skeletal muscle [24, 25], adipose tissue [26, 27], the placenta [28, 29], 
blood [30], blood vessels (i.e. pericytes) [31], and bone marrow [32].  
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1.1.3.2  Scaffolds  
Scaffolds may be derived from a range of biomaterials, and can be either synthetic or naturally-
derived/biologic.  Polymeric biomaterials have been used as a synthetic scaffold to provide the 
required mechanical strength and support needed to withstand arterial blood pressure and flow.  
Synthetic biomaterials may be degradable or non-biodegradable.  Non-biodegradable materials 
utilized for vascular graft applications include Dacron and ePTFE, while biodegradable materials 
consist of polylactic acid (PLA), polyglycolic acid (PGA) and poly (ester-urethane) urea (PEUU) 
[17].  The degradation properties of biodegradable materials may be manipulated such that the 
rate of degradation equals that of extracellular matrix production to ensure the mechanical 
stability of the TEVG.  Natural biopolymers such as fibrin, collagen, elastin and 
glycosaminoglycans (GAGs) have been studied [17].  Other groups have avoided the use of 
synthetic and/or natural biomaterials and have opted for a more biological approach.  L’Heureux 
et al. utilized cell sheet technology in creating a completely biological tubular scaffold [33, 34]. 
1.1.3.3 Cytokines and growth factors 
Cytokines and growth factors drive many of the biochemical processes required for cellular 
proliferation and differentiation, and may be utilized to obtain the desired response of a 
particular cell type.  Growth factors relevant to vascular tissue engineering applications, such as 
vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), basic 
fibroblast growth factor (bFGF), and transforming growth factor beta (TGF-β), have been widely 
studied and are known to be involved in critical cellular functions.  VEGF is widely studied 
because of its role in fetal development and angiogenesis, as CD34+ progenitor cells in the 
presence of VEGF has been shown to promote differentiation toward an endothelial cell lineage 
[35, 36].  PDGF-BB promotes proliferation while also decreasing expression of contractile 
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proteins, leading to a more synthetic, proliferative phenotype [37, 38].  bFGF plays a significant 
role in the wound healing response and angiogenesis via smooth muscle and endothelial cell 
proliferation [39, 40].  TGF-β is well known for its involvement in smooth muscle cell 
phenotype modulation and tissue remodeling via extracellular matrix production at varying 
concentrations  [19].   
1.2 STEM CELLS IN REGENERATIVE MEDICINE APPLICATIONS  
 
Due to the continued organ donor shortage and the aging population, regenerative medicine and 
tissue engineering has emerged as a means of treating diseased and injured organs for patients 
suffering with various debilitations and diseases.  The underlying goal behind all regenerative 
medicine applications is to repair, replace or regenerate tissues and/or organs.  One of the most 
critical components in this field is determining the optimal cell source when utilizing cell-based 
therapies.  Cells are often isolated from donor tissue, expanded ex vivo, seeded onto a matrix or 
scaffold, and then reimplanted into the host recipient.  Cells can be either allogeneic or 
autologous.  An autologous cell line is often desired to avoid any immunogenic effects.  
However, because autologous cells come from the diseased host, these cells may be abnormal 
and potentially difficult to expand in sufficient quantities.  Because of this, stem cells have 
proven to be a viable alternative [41].   
In 1963, Becker et al. was amongst the first to study stem cells, when they injected bone 
marrow cells in the spleens of irradiated mice.  They found that size of the nodule formation on 
the mice spleen was proportional to the cell number they injected, and therefore came to the 
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conclusion that these nodules arose from an individual bone marrow cell [42].  What arose from 
this discovery was that stem cells are capable of self-renewal, a concept that is now intrinsic to 
stem cell behavior.   Therefore, two distinguishing features of stem cells are self-renewal (giving 
rise to new stem cells) and the ability to differentiate in response to the appropriate 
environmental cues.  Generally speaking, stem cells are either embryonic or adult.  Embryonic 
stem cells (ESCs) exhibit pluripotency and therefore are capable of giving rise to the three germ 
layers (endoderm, mesoderm and ectoderm).   
Adult stem cells (non-ESCs) are multipotent due to their ability to only differentiate into 
select cell and tissue types.  These cells more lineage-committed that are lower in the stem cell 
ladder, and therefore do not retain the pluripotent characteristics of ESCs.  Adult stem cells are 
multipotent due to their ability to differentiate toward prescribed lineages, depending on the 
environmental cues they receive.  Non-ESCs can be derived from several tissues, including fat 
[43, 44], muscle [45], and bone marrow [23] to name a few, and may differentiate along different 
lineages when prompted with the appropriate milieu of cytokines, growth factors, and/or 
mechanical stimuli.    They have also been shown to even exist in organs with slower turnover 
rates, such as the liver, brain and β-islets in the pancreas.  While ESCs have been difficult to 
implement due to the ethical concerns, adult stem cells are an exciting and invaluable alternative 
to the regenerative medicine arena.   
1.2.1 Adipose-Derived Stem Cells  
Human fat has proven to be a good source of adipose-derived stem cells, or ADSCs, and been 
shown to have osteogenic capabilities in vitro [46].  ADSCs have been shown to be guided down 
several other lineages in vitro, including chondrogenic [47], hepatic [48], neurogenic [49], and 
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myogenic [50] cell lines.  Researchers have demonstrated cardiomyocytic differentiation 
demonstrating functionality and phenotypic maintenance after 2 months of culture [51].  Upon 
characterization of ADSCs, studies have shown that this particular cell type is phenotypically 
similar to BMSCs [52], yet have varying differentiation potentials [53].  Most relevant to this 
work, however, is the ability of ASCs to differentiate toward a vascular SMC phenotype in 
response to mechanical and chemical stimulation with TGF-β in 2D [54]. 
 
1.2.2 Muscle-Derived Stem Cells 
Muscle-derived stem cells (MDSCs) have been shown to self-renew and have multipotent 
capabilities.  Several varieties of isolation techniques from muscle digests have yielded cells 
capable of giving rise to myogenic, osteogenic, chondrogenic, and adipogenic cell lineages as 
reviewed by Deasy and Huard [24].   These differentiation modalities may be harnessed to treat 
diseases such as muscular dystrophy, while they also may be used as a delivery vehicles and 
therapeutic agents to promote bone remodeling, cardiac tissue repair and stress urinary 
incontinence.   Toward vascular graft applications, these cells have been integrated with 
polymeric scaffolds and implanted in vivo, and have demonstrated the potential to differentiate 
into SMCs upon implantation [55]. 
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1.2.3 Bone Marrow-Derived Mesenchymal Stem Cells  
Bone marrow-derived mesenchymal stem cells, or BMMSCs, are thought to be an ideal cell 
source for tissue engineering and regenerative medicine applications, as they may be readily 
harvested from a patient, while avoiding the ensuing debate over ethical concerns associated with 
the use of ESCs.  It has been known for a significant amount of time that stem cells exist in the 
bone marrow, as they are the most widely studied sources of adult stem cells.  BMMSCs were 
first isolated from bone marrow in the 1960s by Friedenstein [56].  More recently, it was 
determined that these stem cells derive from hematopoietic and mesenchymal lineages, and they 
have been characterized as progenitors based on their use to treat leukemia.  Multipotency can be 
maintained in an undifferentiated state in vitro, while this cell type has the potential to 
differentiate down osteogenic, chondrogenic, neurogenic, and adipogenic lineages [44, 57-60].  
Based on evidence suggesting that these BMMSCs are capable of differentiating into SMCs, 
ECs, and cardiomyocytes, the vascular tissue engineering field has successfully moved forward 
[61-65].  Furthermore, progenitor cells from the bone marrow have been found in circulation and 
have been shown to be involved in neovascular formation [35, 66, 67].  Autologous BMMSCs 
were also utilized in a recent clinical trial where progenitor cells were aspirated from the bone 
marrow, seeded onto the polymer scaffold of a TEVG, and implanted all within the same surgery 
[68].  The clinical relevance of this work underscores the need to understand cardiovascular 
differentiation of BMMSCs.   More interesting and relevant to this work, however, is their ability 
to differentiate toward a smooth muscle cell phenotype in response to mechanical and/or 
chemical stimuli in vitro [37, 69-80].  This will be discussed in more detail in a later section.   
 
 12 
1.3 SMOOTH MUSCLE CELLS (SMCS) 
Smooth muscle cells (SMCs) are derived from the mesodermal layer during embryonic 
development.  Two processes contribute to vessel formation during embryonic development.  
Vasculogenesis, the de novo formation of blood vessels, allow vascular precursor cells to 
differentiate into endothelial cells, which come together to form a hollow tube or blood vessel.  
From these preexisting blood vessels, budding or sprouting of new vessels may occur; a process 
called angiogenesis.   During the development of larger vessels, SMC precursors are recruited to 
the site of new vessel formation and give rise to vascular SMCs [81]. 
SMCs have long been described as having either a contractile or synthetic phenotype, 
depending on the local mechanical and biochemical stimuli.  However, it is now more widely 
recognized that SMC phenotypes exist in a spectrum rather than a two-state model (Figure 1-2) 
[81].  As such, SMCs express different contractile proteins during various states of 
differentiation, as they are plastic due to their dependence on local environmental cues and 
stimuli.   
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Figure 1-2:  Expression of SMC differentiation markers during development.  The cell on the left 
indicates a synthetic SMC.  Expression of various markers exists as a hierarchy, as the cell on the right indicates a 
fully differentiated contractile SMC.  Contractile SMCs express all of the differentiation markers.  Figure adapted 
from [81]. 
 
 
 
1.3.1 SMC Markers 
The primary function of vascular SMCs is contraction.  SMCs exist in a plastic state where they 
may lose their contractile phenotype and become more synthetic.  These different phenotypic 
states are associated with different marker proteins.  For example, contractile phenotypes are less 
proliferative and more quiescent, and express alpha-smooth muscle actin (α-SMA), calponin, 
myosin heavy chain (MHC) SMC markers.  Synthetic phenotypes are associated with 
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proliferation and lack of expression of the above-mentioned SMC markers.  Details about these 
SMC protein markers will be described in the subsequent sections.   
1.3.1.1 α-smooth muscle actin 
Smooth muscle alpha-actin or α-SMA is the most abundant isoform of actin in mature, fully 
differentiated SMCs, comprising 40% of the total cell protein and more than 70% of the total 
actin within an SMC [82].  A high α-SMA protein is necessary for a SMC’s force generating 
capacity, and intrinsic to the SMC contractile machinery [83].  Because of this, α-SMA can be 
evaluated quantitatively to determine the extent of differentiation and maturation of an SMC.  α-
SMA is not exclusively present in SMCs but rather a variety of mesoderm-derived cells that are 
seen in development and wound repair.  Expression of α-SMA may also be induced exogenously 
with the addition of growth factors such as transforming growth factor-beta (TGF-β), as can be 
seen with microvascular endothelial cells and myfibroblasts.  α−SMA is the first protein 
expressed in during vasculogenesis, while also increasing its level of expression during vascular 
development [81]. 
 
1.3.1.2 Calponin 
Calponin is involved with the interaction between f-actin and tropomyosin in a calcium-
independent fashion.  Two isoforms of calponin are known to exist, namely h1-calponin and l-
calponin, for high and low molecular weight respectively.  h2-calponin is a novel variant, and is 
expressed in both SMCs and some non-SMCs, such as lung alveolar cells [84], macrophages 
[85], epidermal keratinocytes and fibroblasts [86].  Unlike h2-caplonin, h1-calponin is exclusive 
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to SMCs, where it is expressed early in aortic development and continues to be expressed in 
mature SMCs [81]. 
 
1.3.1.3 Myosin heavy chain  
Myosin is critical to the contractility of all muscle and non-muscle cells.  Myosin heavy chain 
(MHC) is a subunit of myosin and exists in multiple isoforms, where expression of these 
isoforms is regulated in tissue-specific and developmental stage-related mechanisms.  However, 
the SM-1 and SM-2 isoforms are thought to be exclusive to SMC expression.  SMemb is a third 
isoform of MHC that is found in cultured SMCs as well as human atherosclerotic lesions.  
Because SM-2 expression was only first detectable 10 days postnatally in vascular SMCs 
followed by gradual increases in expression, this confirms that SM-2 MHC is the latest 
differentiation marker of mature SMCs [81]. 
 
1.3.2 Determinants of an SMC Phenotype 
1.3.2.1 Mechanical stimulation of SMCs 
Terminally differentiated vascular SMCs are intrinsically subjected to mechanical forces that 
arise from the pulsatile nature of blood flow.  These mechanical forces primarily consist of cyclic 
strain and pressure, whereby these forces are transmitted through the walls of a blood vessel.  
These forces are crucial in maintaining the functionality, viability, proliferation and protein 
expression of vascular cells, as changes in the mechanical environment may play a role in 
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vascular disease.  An understanding of the role of mechanical stimulation in maintaining the 
contractile vascular SMC phenotype is important in both healthy and disease states.   
As seen in Figure 1-2, SMC phenotype exists as a spectrum, whereby these cells may 
differentiate and dedifferentiate while expressing different contractile proteins.  In 
atherosclerosis, SMCs are of a more synthetic or proliferative phenotype, where they lose 
expression of late differentiation markers such as calponin and MHC.  Conversely, increased 
expression of these late differentiation markers leads to a more contractile phenotype, which are 
necessary to carry out the contractile functions of SMCs in the vasculature [81].  Because blood 
vessels are consistently subjected to mechanical forces in the vessel wall, there is much evidence 
to suggest that these forces are necessary to regulate and maintain the vascular smooth muscle 
phenotype.   
Depending on the location, different mechanical forces are sensed in the vessel wall.  For 
instance, the lumen or endothelial layer is highly subjected to shear stress due to blood flow.  
The focus of this work, however, will highlight the effect of mechanical strain as sensed by the 
medial layer of blood vessels.   
Mechanical strain has been studied extensively in 2D formulations [87-90] where cells 
are typically cultured on deformable substrates so as to apply various strains and frequencies to 
the substrate, which may in turn be sensed by the cells.  Equibiaxial and uniaxial cyclic 
mechanical strains have been traditionally used to better understand the effects of these strains in 
vitro.    
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1.3.2.1.1 Equibiaxial strain 
The effect of equibiaxial strain, where stain is imposed equally in two directions (Figure 1-3A), 
has been studied to elucidate the response of SMCs to mechanical stimulation.  Beginning 
attempts at creating a device to subject cells to biaxial stretch was initiated by Banes et al [91], 
by creating a negative vacuum pressure beneath the deformable substrate, as seen in Figure 1-
3B.  However, this approach creates a non-uniform strain at the edges of the deformable 
substrate, thereby creating inhomogeneous strain distribution.  More recent attempts have solved 
this issue by deforming the substrate over a post, and therefore creating a more uniform strain 
distribution.  The Flexcell® strain unit (Hillsborough, NC) was born by coupling the idea of an 
applied vacuum over a post (Figure 1-3C).  Other devices have been created by fabricating a 
moveable circular post that imposes cyclic equibiaxial strain without the use of a vacuum 
pressure [92] (Figure 1-3D).   
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Figure 1-3:  Mechanical devices used to induce equibiaxial strain.  (A)  Schematic of application of 
equibaxial strain.  (B)  Apparatus used to apply equibiaxial strain with the application of a vacuum directly under a 
deformable substrate.  (C)  Apparatus used to apply equibiaxial strain with the application of a vacuum over a 
circular post.  (D)  Application of equibiaxial stretch utilizing a moveable post (as opposed to a vacuum).  Figure 
adapted from [93]. 
 
 
 
The goal behind a mechanical straining regimen is to replicate the forces seen in vivo.  
Earlier work by Birukov et al has shown that equibiaxial strain can influence SMC phenotype, 
where they demonstrated that equibiaxial strain led to an increase in h-caldesmon expression 
[94].  Other studies have reported matrix-dependent effects, where laminin or collagen type-I-
coated substrates led to increases in SM-1 expression, while SMCs cultured on fibronectin led to 
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no upregulation of SM-1 [95].  This work suggests that cell-matrix interactions, when coupled 
with mechanical stimulation, may play a role in the maintenance of an SMC phenotype.   
While much of this work suggests that equibiaxial mechanical strain plays a substantial 
role regulating a contractile SMC phenotype, as evidenced by upregulation of late differentiation 
markers, others have demonstrated a more proliferative and synthetic response to cyclic 
equiabiaxial stretch.  Sudhir et al. and Yang et al. have reported SMC proliferation [39, 96].  
Others have again underscored the cell-matrix interdependence and have noted increased 
proliferation of SMCs on fibronectin- and vitronectin-coated membranes, with no change in 
SMC proliferation on laminin- and collagen type I-coated membranes [97]. 
 
1.3.2.1.2 Uniaxial strain 
Because SMCs in a native blood vessel align in the circumferential direction and have an 
elongated morphology which is necessary for contraction of the vessel wall, uniaxial strain has 
been utilized to study strain effects on SMCs, as it better mimics physiologic strain than 
equiaxial strain.  Uniaxial strain is the application of strain along one axis.  Several devices have 
been created to apply unaxial strain to cells in 2D.  Park et al. [98] created a device where the 
substrate is fixed at one end and stretched uniaxially by pulling on the non-fixed end (see Figure 
1-4).   However, this again creates a non-uniform strain distribution at the fixed edge.  The 
versatility of Flexcell® allows for the aforementioned circular posts to be replaced by arctangle 
posts.  As such, a uniaxial strain may be imposed on a flexible substrate, based on the geometry 
of the post (see Figure 1-4).   
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Figure 1-4:  Mechanical devices used to induce uniaxial strain.  (A)  Application of uniaxial stretch of a 
deformable membrane.  (B)  Application of uniaxial strain using an applied vacuum over an artangle post.  Figure 
adapted from [93]. 
 
 
 
In vivo, vascular SMCs are subjected to 5-15% cyclic circumferential strain, depending 
on the location in the vasculature [99].  Once explanted and cultured in vitro in a static 
environment, SMCs begin to downregulate their expression of SMC proteins such as MHC and 
calponin, and thereby exhibiting a shift from a contractile phenotype to a more synthetic 
phenotype [19, 100].  This underscores the dynamic nature of the vasculature and its importance 
in maintaining a functional SMC phenotype.  SMCs are highly responsive to magnitude and 
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frequency of stretch, where lower stretch magnitudes lead to more proliferation [19].  
Physiologic magnitudes of stretch are required to maintain a contractile and quiescent phenotype, 
where higher magnitude of strain has been shown to increase proliferation, apoptosis, and ECM 
production, and therefore shifting toward a  more synthetic phenotype [19].  
 
1.3.2.1.3 Need for 3D stimulation 
While these experiments have provided much insight on the response of SMCs to 2D culture, the 
application of strain in 3D better mimics the vascular environment in vivo.  SMCs behave 
differently in 3D as compared to 2D.  In vitro culture of cells in 2D looking into the effect of 
uniaxial strain on vascular cells demonstrated perpendicular alignment relative to the direction of 
strain [101].  This preferential alignment may be due to an effort to minimize the stress applied 
to the cells, and cell orientation may lead to different cellular responses to mechanical 
stimulation. In contrast, SMCs in a 3D dynamic environment align in the direction of stretch and 
have a more elongated, spindle-shaped morphology [78]. 
The mechanical and extracellular matrix environment surrounding SMCs in vivo is 
important in maintaining cell function and phenotype.  SMCs in vivo are inherently subjected to 
mechanical forces, including cyclic mechanical strain.  When removed from this mechanically-
vigorous environment to an in vitro culture environment, SMCs begin to downregulate SMC-
specific proteins necessary for the maintenance of a contractile phenotype.  However, once 
SMCs are subjected to mechanical forces in vitro, SMCs are capable of retaining a differentiated 
phenotype.  Several researchers have successfully demonstrated the maintenance of an SMC 
phenotype ex vivo in a 3D environment coupled with mechanical strain [37, 72, 93].   
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1.3.2.2 Chemical stimulation of SMCs 
Growth factors are essential in promoting proliferation and differentiation of stem cells towards a 
desired phenotype.  There are several growth factors that are known to stimulate smooth muscle 
and progenitor cells, specifically basic fibroblast growth factor (bFGF), platelet derived growth 
factor (PDGF), and transforming growth factor beta (TGF-β) [17].    
 
1.3.2.2.1 bFGF 
bFGF plays a role in the wound healing response and angiogenesis via the proliferation of SMCs 
and ECs at the site of injured tissue.  bFGF coupled with other biochemicals, such as ascorbic 
acid, has been shown to act synergistically in the production of ECM and proliferation of SMCs  
[40]. 
 
1.3.2.2.2 PDGF 
PDGF causes proliferation of SMCs by allowing cells pass from G0 to the G1 phase of the cell 
cycle.  Furthermore, several researchers have reported that the PDGF suppresses the expression 
of SMC markers [81, 102].  Others have also demonstrated synergy between mechanical 
stimulation and PDGF supplementation in 3D.  Mechanical stimulation of SMCs and PDGF 
stimulation has been shown to decrease expression of contractile proteins [37]. 
 
1.3.2.2.3 TGF-β 
When considering all of the biochemical factors that may play a role in vascular development, 
TGF-β is of particular interest as several researchers have demonstrated its role in maintaining 
terminally differentiated SMCs, where it has been shown to up-regulate SMC markers, 
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including α-SMA, h1-calponin, and MHC [103, 104].  Furthermore, it has also been shown that 
50% of TGF-β knockout mice die in utero at days 10.5 – 11.5 with vascular defects and 
compromised vessel wall integrity [105].  This work suggests that TGF-β is necessary for SMC 
maturation during vasculogenesis and angiogenesis during maturation.   
SMCs respond to TGF-β in a concentration-dependent manner.  Lower concentrations of 
TGF-β (1-2 fg/ml) leads to SMC proliferation through the activation of PDGF receptors [106, 
107].  Conversely, higher concentrations of TGF-β (10 pg/ml – 10 ng/ml) has been shown to 
inhibit proliferation by downregulating PDGF receptors [107, 108]. 
Lastly, TGF-β has been shown to increase ECM production by both increasing the 
expression of type I collagen while also decreasing matrix metalloproteinase (MMP) activity 
[106, 109].  
1.3.2.3 Combined mechanical and chemical stimulation of SMCs 
The most physiologically significant approach in studying maintenance of an SMC phenotype is 
combining the mechanical and chemical factors to create a more complex milieu in which to 
study differentiation.  Stegemann and Nerem used SMCs embedded in a 3D collagen type I 
matrix, and subjected these constructs to cyclic mechanical strain with biochemical stimulation.  
Biochemical stimulation was added exogenously to the media using PDGF and TGF-
β.  Mechanical stimulation was applied using a bioreactor, and gel compaction, cell proliferation 
and α-SMA expression were subsequently assessed.   Mechanical strain was shown to cause an 
increase in compaction and proliferation as compared to statically cultured controls [37].  While 
PDGF increased cell proliferation and decreased α-SMA expression, TGF-β supplementation led 
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to decreased cell proliferation and an increase in α-SMA expression.  These results indicate that 
mechanical and various chemical stimuli may work together in regulating SMC phenotype [37]. 
1.4 ADULT STEM CELLS  
Adult stem cells provide an exciting alternative to ESCs toward regenerative medicine 
applications.  Several sources of adult stem cells have been expanded upon briefly in Chapter 1.  
The focus of this chapter will now be on mesenchymal stem cells derived from bone marrow, or 
bone marrow mesenchymal stem cells (BMMSCs), and how researchers have guided their 
differentiation toward a desired phenotype.   
 
1.4.1 Determinants of Differentiation of MSCs 
1.4.1.1 Mechanical stimulation of MSCs 
It has been discussed in section 1.3 that mechanical stimulation is required to maintain the 
terminally differentiated phenotype of SMCs.  However, it is necessary to elucidate role of 
mechanical strain on the differentiation of BMMSCs.  While several research groups have 
utilized mechanical stimulation to differentiate BMMSCs toward several different cell lineages, 
the following sections will be focused on differentiation toward a vascular SMC phenotype    
Mechanical strain has been shown have effects in both 2D and 3D culture, and will be discussed 
further in the following sections.   
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1.4.1.1.1 2D mechanical strain 
Our group was among the pioneering efforts assessing the ability of BMMSCs to differentiate 
using mechanical stimulation in 2D.  Hamilton et al. have demonstrated that BMMSCs 
differentiate toward a vascular SMC phenotype while decreasing proliferation in response to 
mechanical stimuli [74].  Other groups have corroborated these findings.  Park et al. revealed 
that uniaxial cyclic stretch is required for SMC gene transcription and subsequent SMC protein 
production [98].  As previously mentioned, mechanical stimulation in 2D leads to cellular 
realignment perpendicular to the direction of strain.  The findings of Park et al. were based on 
gene expression from these reoriented cells.  Because SMCs in vivo are aligned in the direction 
of strain, Kurpinski et al. sought to force the alignment of BMMSCs via channel fabrication, 
while still maintaining two-dimensionality.  Mechanical stimulation of BMMSCs that were 
forced to align parallel to the direction of stretch with the use of channels led to a greater 
increase in SMC markers as compared to BMMSCs stretched without forced alignment [76]. 
 
1.4.1.1.2 3D mechanical strain 
As noted previously, mechanical strain in 3D better simulates the mechanical environment in 
vivo, and thus it is advantageous to study stem cell differentiation in this manner.  Altman et al. 
used 3D collagen gels and rotational strains to induce MSC differentiation, while also showing 
an increase in collagen I and III expression [69].  Cummings et al. have performed studies on 3D 
collagen/fibrin gel mixtures using BMMSCs, and have demonstrated a stronger ultimate tensile 
stress with upregulation in SMC gene expression when compared to statically cultured gels [72].  
Most recently, our group published data on the effect of mechanical stimulation on bone marrow 
stem cells, and it was shown that mechanical stimulation in 3D promotes differentiation toward 
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an SMC phenotype, promotes cellular alignment in the direction of strain, and an increase in 
collagen production when compared to static controls [78]. 
 
1.4.1.2 Chemical stimulation of MSCs 
Differentiation of BMMSCs may be induced by several different biological factors, similar to 
those described in Section 1.3.2.2.  While more work has been done to the demonstrate 
maintenance of a terminally differentiated SMC phenotype, others have looked towards 
differentiation of mesenchymal stem cells toward an SMC phenotype. Several groups have 
demonstrated the ability to regulate BMMSC differentiation toward an SMC phenotype utilizing 
PDGF-BB [80, 110], TGF-β [75, 111], ascorbic acid (AA) [70];  and retinoic acid [71, 112].  A 
recent paper published by Narita et al. focused on the role of TGF-β and AA on differentiation of 
human MSCs into SMCs [77]. 
1.4.1.2.1 PDGF 
While PDGF has been shown to decrease SMC protein expression in smooth muscle cells, 
several researchers have demonstrated its role in promoting an SMC-like phenotype in bone 
marrow-derived mesenchymal stem cells.   Yoon et al. induced differentiation of human bone 
marrow-derived multipotent stem cells (hBMSCs) in vitro with culture media supplemented with 
PDGF-BB.  Following 14 days of culture, hBMSCs stained positive for α-SMA and calponin.  
De novo expression of SMC genes, including α-SMA, SM22α and SM1 was confirmed via RT-
PCR [113].  Others have demonstrated the role of PDGF in differentiating circulating smooth 
muscle progenitor cells (originating from the bone marrow) via SMC protein expression [80]. 
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1.4.1.2.2 Retinoic Acid 
Retinoids have been shown to play a role in vasculogenesis in many species [112].  In an effort 
to better understand the mechanism behind SMC differentiation, researchers have cultured P19 
embryonal carcinoma cells with high concentrations retinoic acid, and have demonstrated SM1-
positive (an isoform of MHC) cells [114].  Others have confirmed these findings by 
demonstrating treatment of this same cell line with PDGF leads to differentiation toward an SMC 
phenotype via expression of SMC-specific proteins, while also exhibiting functionality via the 
response to various contractile agents [71].  
1.4.1.2.3 Ascorbic Acid 
Arakawa et al. have demonstrated the response of a bone marrow stromal cell line to ascorbic 
acid via inducible expression of SMC-specific genes, namely α-SMA, SM22α, h-caldesmon and 
h-calponin when cultured in differentiation medium [70].  Others have confirmed these findings.  
Narita et al. demonstrated a significant increase in SM22α expression in response to ascorbic 
acid supplementation.  In the same publication, this group also examined additive effects of AA 
and TGF-β supplementation on BMMSCs, and has demonstrated upregulation of SMC genes 
when compared to TGF-β or AA stimulation alone [77]. 
1.4.1.2.4 TGF-β 
TGF-β has been shown to play a role mesenchymal in stem cell differentiation toward an SMC 
phenotype both in vitro and in vivo.  Kinner et al. examined the effects of TGF-β on α-SMA 
expression, and results from their work concluded that TGF-β significantly upregulated 
expression of α-SMA [75].  As mentioned previously, Narita et al. looked in the role of both 
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TGF-β and ascorbic acid supplementation on BMMSCs, while also examining the role of TGF-
β alone.  BMMSCs cultured with TGF-β revealed an upregulation of SMC-specific genes in a 
dose-dependent manner [77].  Work by Gong and Niklason has corroborated these findings using 
human BMMSCs.  Qualitative protein expression of α-SMA and calponin were demonstrated in 
cells supplemented with TGF-β growth media [73].   
1.4.1.3 Combined mechanical and chemical stimulation of MSCs 
Growth factors in conjunction with mechanical stimulation in 2D have been shown to have a 
significant effect in regulating the cell phenotype.  Several researchers have explored the 
possible synergism between chemical and mechanical stimulation, and the subsequent regulation 
of SMC markers.  TGF-β together with mechanical strain increased α-SMA when compared to 
mechanical strain alone [37].  More recent work shows that embryonic mesenchymal stem cells 
cultured under cyclic strain with TGF-β supplementation revealed an increase in mRNA levels of 
α-SMA and MHC by 10- and 2-fold respectively, when compared to statically cultured cells 
[79].  These findings suggest that chemical and mechanical factors may work together to 
modulate the cell phenotype, when compared to each stimulus alone.  This work has led to the 
formulation of our specific hypothesis and will be discussed in Chapter 2.   
Most recent work by Gong and Niklason utilized human bone marrow-derived 
mesenchymal stem cells embedded in a biodegradable scaffold, and studied their ability to 
differentiate into SMCs.  Using a biomimetic perfusion system, cyclic strain was combined with 
exogenous growth factors to investigate the effects on SMC proliferation and differentiation.  
Qualitative and quantitative protein expression was demonstrated for early and midstage SMC 
differentiation markers.  This work demonstrates the ability of BMMSCs to be successfully 
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integrated into scaffolds for vascular graft applications, while underscoring their ability to 
differentiate into SMCs in response to the appropriate mechanical and chemical environment 
[73]. 
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2.0  SPECIFIC AIMS 
Multi-potential progenitor cells may serve as an alternative source of terminally differentiated 
cells for tissue engineering applications.  The bone marrow has been shown to contain these 
multi-potent progenitor cells, and they have been shown to differentiate toward several 
hematopoietic and mesenchymal lineages [60, 115-118].  Bone marrow mesenchymal stem cells 
(BMMSCs) may alleviate issues associated with cell sourcing [22], as they are easily obtained 
and are an autologous cell source.  Despite this, the use of BMMSCs towards vascular 
applications is still preliminary.  Biochemical differentiation has been traditionally used to 
provide the appropriate environmental cues to direct BMMSC differentiation [57, 60, 63].  
However, chemical stimuli used in vitro is required to be maintained in vivo to retain the desired 
differential effects.  Without the appropriate chemical stimulation, the differentiated phenotype 
may not be retained in vivo.  This further emphasized the need to study the effects of the 
mechanical environment on BMMSCs, as it is well known that the mechanical environment 
plays a pivotal role in maintaining the phenotype of terminally differentiated cells [119-124].  
Recent data suggests that BMMSCs subjected to a mechanical environment may differentiate 
towards a SMC phenotype [74].  Growth factors in conjunction with mechanical stimulation 
have been shown to have a significant effect in regulating the cell phenotype.  Simultaneous 
stimulation with mechanical strain and TGF-β has been shown to increase α-actin expression 
when compared to mechanical strain alone [37, 79].  This work suggests that mechanical and 
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chemical factors may work together to promote differentiation towards a SMC phenotype [37].  
Consequently, the purpose of this research was to further investigate the effects of both 
mechanical and chemical stimulation.   
 
Hypothesis: Uniaxial cyclic tension and chemical stimulation with TGF-β will 
differentiate BMMSCs towards an SMC-like lineage in a synergistic manner. 
 
2.1 SPECIFIC AIM 1 
To determine the effect of cyclic tension and frequency on BMMSCs in a 3D fibrin matrix. 
2.2 SPECIFIC AIM 2 
To determine the synergistic effects of mechanical and chemical stimulation with TGF-β at 
various strains and frequencies as in Specific Aim 1.   
 
Mechanical stimulation has been demonstrated to play a role in both the maintenance of an SMC 
phenotype and differentiation toward an SMC phenotype of cells derived from mesenchymal 
lineages.  Similarly, chemical stimulation has proven to both maintain and promote an SMC 
phenotype.  Other groups have then begun to question whether there are any syngeristic effects 
between mechanical and chemical stimulation, and the role in which simultaneous stimulation 
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may play in promoting an SMC phenotype in BMMSCs.  In the first specific aim, BMMSCs will 
be subjected to uniaxial mechanical stimulation alone.  In the second specific aim, BMMSCs will 
be subjected to uniaxial mechanical stimulation with simultaneous TGF-β supplementation.  The 
effects of mechanical stimulation alone and the combined effects of mechanical and chemical 
stimulation will be assessed to determine SMC differentiation of BMMSCs.  Chapter 3 will 
discuss the experimental design and the methods utilized for this thesis.  Chapter 4 will show the 
results obtained from this work, and Chapter 5 will discuss these results in greater detail.  
Chapter 6 will relay final thoughts and conclusions, and Chapter 7 will discuss potential future 
work for this project. 
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3.0  METHODS  
3.1 CELL CULTURE AND SOURCE 
Rat bone marrow mesenchymal stem cells (BMMSCs) were obtained from the Tulane Center for 
Gene Therapy as an established cell source [125].  According to their protocol, BMMSCs were 
harvested from the femurs of adolescent Lewis rats and have been characterized as CD90+ and 
CD59+ [125].  BMMSCs were plated at a density of 200 cells/cm2 and cultured at 37ºC and 5% 
CO2 in α-Modified Eagle’s Medium (α-MEM, Invitrogen) supplemented with 20% fetal bovine 
serum (FBS, Atlanta Biologicals, Atlanta, GA) 1% antibiotic/antimicotic (Invitrogen) and 10mM 
L-Glutamine (Invitrogen).  The lot of FBS was selected for optimal growth based on the growth 
kinetics [126].  BMMSCs were expanded until confluent, and used up to passage 10.  Media 
changes were preformed every 48 hours with complete media.   
Once cells reached confluence, BMMSCs were rinsed in Dulbecco’s phosphate buffered 
saline (PBS) and trypsinized using 0.1% tryspin (Invitrogen) at 5% CO2 and 37ºC for 5 minutes 
until cells were detached.  Media was then added to stop the effects of trypsin, and the cell 
suspension was transferred to a conical tube for centrifugation at 1200 rpm for 5 minutes.   
Following centrifugation, the cell pellet was resuspended in an appropriate volume of complete 
media to achieve a desired concentration to create 3D constructs, as described in the next section. 
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3.2 FABRICATION OF 3D TISSUE TRAIN CONSTRUCTS 
 
To create a 3D construct that was capable of withstanding cyclic stretch, a fibrin gel was utilized, 
as it is capable of being molded into the FlexcellTM Tissue-TrainTM (Flexcell, Hillsborough, NC) 
troughs utilized in our experimental model.  Fibrin gels were created via an enzymatic reaction 
with fibrinogen and thrombin, allowing cells to be easily integrated homogeneously into the 
constructs.  A cell/fibrinogen solution was created by suspending 1x106 cells/ml in a solution of 
fibrinogen (5 mg/mL, Sigma Aldrich, St. Louis, MO) supplemented with 6-aminohexanoic acid 
(1 mg/mL, Sigma-Aldrich, St. Louis, MO).   A thrombin solution (2.5 units/ml, Sigma-Aldrich, 
St. Louis, MO) created with α-MEM was made separately and kept aside on ice. TGF-β was 
supplemented to the thrombin solution at a concentration of 10 ng/mL for experimental groups 
with TGF-β supplementation. To form a fibrin gel, the thrombin solution was added to the 
fibrinogen/cell suspension, mixed via conical tube inversion, then 180 μl of the 
fibrinogen/thrombin mixture was added to each well (see Figure 3-1).   
Constructs were allowed to gelate at 37ºC and 5% CO2 for 30 minutes, then complete 
media was added to each well.  For constructs made with TGF-β, complete media supplemented 
with 10 ng/mL of TGF-β was added following gelation.   Samples were incubated for 48 hours to 
allow for compaction before beginning mechanical straining regimens.  See Appendix A for 
more details on tissue train construct fabrication.   
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Figure 3-1:  Creation of a fibrin gel using tissue train.  (A)  Side view of tissue train posts with no 
applied vacuum.  (B)  Application of a vacuum through vacuum holes in tissue train troughs.  Deformable 
membrane is pulled into the trough via a vacuum, allowing for the addition a gel solution into the trough.  (C)  
Anchor stems allow for gels to attach completely at ends, and the compacted gel may be released from the vacuum 
following compaction.  Figure adapted from www.flexcellint.com.   
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3.3 DETERMINATION OF OPTIMAL LOCATION FOR TGF-β IN THE 
EXPERIMENTAL MODEL 
Based on a literature search, it was determined that a concentration of 10 ng/ml of TGF-β would 
be appropriate for this application, as a concentration any higher than 10 ng/ml was shown to 
have no additional effects.  Because growth factors are expensive, it was important to determine 
where the addition of TGF-β would be made for the desired effects: either added with the 
construct, supplemented to the media, both, or neither (see Figure 3-2 and Figure 3-3 for 
schematic).  In the event that TGF-β appeared to have no effect, this would not have been 
pursued further.  Therefore, for this purpose, constructs were fabricated with TGF-β in the 
construct, in the media, or in both the construct and media.  The control group had no additional 
TGF-β in either location.  To conclude where TGF-β exerted the greatest effects, constructs were 
fabricated as described previously, and subjected to the same experimental conditions (i.e. CS, 
SS or FF) with the noted locations of TGF-β.  Samples were then processed as described in 
Section 3.6.2 and assessed under phalloidin staining.  Constructs were wet mounted in PBS and 
viewed under a confocal microscope as described in Section 3.6.4.  Z-stacks created during 
microscopy were subsequently analyzed and f-actin was quantified.   
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Figure 3-2:  Schematic of location of TGF-beta in experimental model for CS and SS groups.  (A) No 
TGF-beta.  (B)  TGF-beta in the construct.  (C) TGF-beta supplemented to the media.  (D)  TGF-beta added to both 
the construct and media. 
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Figure 3-3:  Schematic of location of TGF-beta in experimental model for FF groups.  (A) No TGF-
beta.  (B)  TGF-beta in the construct.  (C) TGF-beta supplemented to the media.  (D)  TGF-beta added to both the 
construct and media. 
3.4 EXPERIMENTAL DESIGN 
3.4.1 Flexcell  
For experimental conditions requiring a cyclic straining regimen, the Flexercell FX4000TTM 
Tissue TrainTM unit was utilized to create cyclic stretch imposed in fibrin gel constructs.   This 
system works via a vacuum applied underneath culture plates with deformable membranes.  The 
flexible membrane surfaces are stretched over rigid posts under the applied vacuum, allowing for 
a prescribed direction of stretch.  In these particular experiments, we utilized an arctangle post to 
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impose a uniaxial cyclic strain on the fibrin constructs.  The vacuum can be regulated via a 
computer-controlled system, allowing for control over various strain magnitudes and frequencies 
desired for a particular cyclic straining regimen.  The baseplates allow for up to four 6-well 
tissue train plates to be stretched at once (see Figure 3-4).  
 
 
Figure 3-4:  (A) Flexcell device and (B) top view of tissue train plate.  Figure adapted from 
www.flexcellint.com.   
 
 
 
3.4.2 Experimental Groups  
The constructs were divided into 6 experimental groups: cyclic stretch (CS), static stress (SS), 
and free float (FF) control (stress- and strain-free), and each group was studied with (+) and 
without (-) TGF-β.  Once CS and SS samples were compacted after the 48 hour period, tissue 
train constructs were released from the bottom of the plates in between the anchors using a cell 
scraper.  This was to allow for a homogeneous strain distribution along the longitudinal direction 
of the constructs.  The CS constructs were subjected to 10% strain at a frequency of 1 Hz for 6 
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days.  A human-physiologic strain and frequency was chosen so as to best mimic the mechanical 
environment in the human arterial system in vivo.  Parameters related to rat-physiologic strains 
and frequencies may have been relevant, however these strains and frequencies would not be 
achievable in the FlexercellTM system.  The SS groups were created in the same manner, 
however these constructs remained in static conditions for the duration of the experiment.  
Lastly, FF groups were created in 12-well plates (i.e. not placed in tissue train troughs within the 
tissue train plates) to allow for gels to freely compact in all directions.  Briefly, the fibrin/cell 
suspension was pipetted into a 12-well plate, and gels remained attached to the bottom surface of 
the plates for 48 hours.  Following the 48 hour compaction period, fibrin gels were released from 
the bottom using a cell scraper, allowing them to be ‘free floating’, or stress- and strain-free, for 
the duration of the experimental period.  These experimental groups are visualized and 
summarized in Figure 3-5.   
All experiments were completed in parallel with groups containing TGF-β under the 
same conditions.  Therefore, each experiment consisted of 6 experimental groups:  cyclic stretch 
(CS), static stress (SS), and free float (FF), with (+) and without (-) TGF-β.  For the remainder of 
this thesis, groups will be denoted as CS+, SS+, FF+, CS-, SS- and FF- to designate with or 
without the addition of TGF-β, respectively.   
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Figure 3-5:  Schematic of experimental groups.  CS groups are fabricated in tissue train troughs and are 
subjected to 10% strain and 1Hz.  SS samples are created in a similar manner, however are not subjected to any 
external mechanical forces.  FF groups are created in 12-well plates and are allowed to compact freely in all 
directions upon releasing the gels from the bottom of the wells following the compaction period.   
3.5 APPLICATION OF CYCLIC STRETCH  
Tissue train plates were mounted on the FX4000T baseplates and connected to the strain unit 
following the 48 hour compaction period.  Cyclic stretch was applied via membrane deformation 
from the applied vacuum across an arctangle post, thereby creating uniaxial cyclic strain across 
the tissue train constructs.  SS and FF groups required no additional manipulation. 
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3.6 ENDPOINT ANALYSIS  
3.6.1 Viability  
To measure viability and quantify BMMSC proliferation, samples were evaluated using an MTT 
assay.  Briefly, constructs were added to a 96-well plate with 200 µl of α-MEM and 20 µl of 
Thyazolyl Blue Tetrazolium Bromide (MTT solution, Sigma-Aldrich, St. Louis, MO), and 
incubated at 37ºC and 5% CO2 for 4 hours to allow for crystal formation.  Following the 
incubation step, 220 μl of the α-MEM + MTT solution was removed, then 200 μl 0.04N HCl in 
2-propanol were added to dissolve the crystals and kept at 4ºC in the dark for 24 hours.  Using a 
microplate reader (Bio Rad, Hercules, CA), absorbance readings for 100 µl of each sample were 
taken, and a final fold increase in cell number was calculated using a standard curve based on 
known cell concentrations.   
 
3.6.2 Morphology  
Following the termination of an experiment, samples were rinsed in PBS, fixed with 4% 
paraformaldehyde, rinsed 5 times with PBS, and then incubated in 0.1% Triton-X 100 to 
permeabilize the cell membranes.  Samples were then incubated with Alexa 488-conjugated 
phalloidin (Sigma-Aldrich, St. Louis, MO) for 60 minutes.  Samples were then washed with PBS 
5 times to remove any unbound phalloidin, and then counter-stained with DAPI.  All samples 
were wet-mounted with PBS and viewed under an inverted confocal microscope (Olympus 
F1000).  Details of the image acquisition process will be described in greater detail in a 
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subsequent section.  Images were analyzed by calculating the stress filament area for each image 
in the z-stack.  Filaments were evaluated using gray-scale thresholding, and the area of stress 
filaments per cell was measured using MetatMorph Image analysis software (v 6.3, Molecular 
Devices, USA).  Thresholded filaments were measured in pixels and normalized to the cell 
number for each image in the z-stack.   
 
3.6.3 Immunohistochemistry  
To evaluate SMC phenotype via immunofluorescence, samples were fixed in 4% 
paraformaldehyde, washed 5 times in PBS, and then incubated in 0.1% Triton-X 100 to 
permeabilize the cell membranes.  Samples were blocked with 5% normal donkey serum in PBS 
plus 0.5% bovine serum albumin (BSA, Equitech-bio, Kerrville, TX) and 0.15% glycine (Sigma-
Aldrich, St. Louis, MO) for 45 minutes to prevent nonspecific binding of primary antibody.  
Samples were then rinsed again with PBS, and incubated with primary antibodies, namely α-
smooth muscle actin (α-SMA), h1-calponin, and myosin heavy chain (MHC).  See Table 3-1 
below for details on the antibodies used.  Primary delete samples were not incubated with 
primary antibody, and served to set the threshold for imaging all other samples.    After washing 
with PBS to remove unbound primary antibody, samples were incubated with DAM 488-
conjugated secondary antibody, counterstained with DAPI, and then wet-mounted and viewed 
under an inverted confocal microscope (Olympus F1000).  Details of the image acquisition 
process will be described in greater detail in Section 3.5.4. Images were evaluated qualitatively 
by inspection to determine differentiation.   
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Table 3-1:  Antibodies used for qualitative SMC phenotype characterization. 
 
 
3.6.4 Confocal Microscopy  
As noted previously, all samples requiring immunofluorescent imaging were wet mounted in 
PBS and viewed under an inverted confocal microscope.  Fluorescent microscopy was preformed 
at 40X for all samples.  Primary delete samples were viewed under the FITC filter and then used 
to set the threshold intensity. All samples were viewed at this intensity or less to ensure there was 
no non-specific binding of secondary antibody and to eliminate any background signal.  Because 
samples were not sectioned, but rather mounted in 3D, z-stacks were created for all samples, and 
later reconfigured in MetaMorph (version 7.0, Downingtown, PA) Image analysis software as 
one, combined image.   
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3.6.5 Histology  
Following the termination of an experiment, samples were fixed in 4% paraformaldehyde and 
rinsed in PBS.  Samples were then fixed in 10% neutral buffered formalin for 1 hour and 
subsequently embedded in paraffin blocks and sectioned using a Shandon Finesse microtome 
(Thermo Shandon, Pittsburgh, PA) and mounted to slides.   To evaluate collagen production, 
samples were stained with Masson’s Trichrome (MT) and picrosirius red (PSR).  To evaluate 
cell morphology within the constructs, constructs were stained with H&E.  Samples were viewed 
under brightfield (Olympus Provis), and images were qualitatively assessed for collagen 
production and overall morphology.  All images were taken at identical exposure times for a 
given experiment.  For PSR-stained samples, a light polarizer was necessary to measure the 
birefringence.   
 
3.7 STATISTICAL ANALYSES  
All experiments and endpoints were completed 5 times unless otherwise noted in the results 
section.  All data is reported as mean ± standard error of the mean (SEM).  Statistical analyses 
were performed using Microsoft Excel.  A paired t-test was utilized to compare groups with and 
without TGF-β.  A p-value < 0.05 was considered significant.   
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4.0  RESULTS 
4.1 DETERMINATION OF OPTIMAL LOCATION FOR TGF-β IN THE 
EXPERIMENTAL MODEL 
Experimental groups receiving TGF-β in both the construct and media in SS and FF 
conditions led to greatest the stress filament area per cell.  In the CS group, constructs fabricated 
with TGF-β in the construct only led to the greatest increase in pixel density of f-actin filaments 
per cell.  This was considered an anomaly as this data is a result of one experiment. Therefore, 
because the addition of TGF-β would not cause any detrimental effects, it was concluded that 
TGF-β will be added to both the construct and media for the subsequent experiments.   See 
Figures 4-1 and 4-2.   
 47 
 
Figure 4-1:  F-actin images to determine location optimal location of TGF-beta in the experimental 
design.  Images based on a single experiment.  F-actin fibers are in green; nuclei are seen in blue.  All images taken 
at 40x.   
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Figure 4-2:  Calculated stress filament area/cell in determination of optimal location of TGF-β.  Data 
shown is a result of one experiment.   
 
 
 
4.2 VIABILITY  
BMMSCs effectively integrated into fibrin gel constructs, and cells remained viable throughout 
the experimental period, as evidenced by the MTT assay (Figure 4-3).  The CS+ group yielded 
the greatest fold increase in cell number when compared to all other experimental conditions.  
When comparing within the experimental groups, both static stress and free float groups 
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demonstrated a greater fold-increase over day 0 when there was no TGF-β supplementation.  
However, in the presence of cyclic strain, TGF-β supplementation led to a greater fold-increase 
in cell number as compared to control.  Statistical analysis revealed a significant fold-increase in 
cell number when comparing CS+ to FF+ and SS+ (p < 0.001 and p < 0.01, respectively).  CS- 
and SS- groups also demonstrated a significant fold-increase in cell number when compared to 
FF- (p < 0.01 and p = 0.03 respectively).    
 
 
 
Figure 4-3:  MTT Assay.  Data represented as mean ± SEM, and based on n = 4.  Blue bars indicate 
groups with TGF-β; purple bars indicate samples without TGF-β.  *, #, and ^ indicates a significant difference 
(p<0.05) when compared to the FF+, FF- and SS+ groups, respectively.     
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4.3 MORPHOLOGY  
4.3.1 F-actin 
The presence of either cyclic strain or static stress had a profound impact on the cell alignment in 
these fibrin gel constructs.  A qualitative assessment demonstrates that CS+/- and SS+/- groups 
align parallel to the direction of strain or static stress (see Figure 4-4 for representative images, 
and Appendix D for all images from all experiments).  Unlike CS+/- and SS+/- groups, FF+/- 
groups exhibited random cellular orientation.   The presence of TGF-β vs. no TGF-β had no 
effect on cell alignment within the constructs.   
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Figure 4-4:  Phalloidin staining of CS, SS and FF groups with (+) and without (-) TGF-beta.  Arrows 
indicate the direction of stretch.  F-actin fibers are in green; nuclei are seen in blue.  Data shown is representative of 
all experiments.  See Appendix D for images from all experiments.  All images taken at 40x.   
 
 
Quantification of the f-actin fibers allows for a better understanding of the relative differences 
between experimental groups.  F-actin images (such as those in Figure 4-4) were quantified as 
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described in Section 3.6.2 and data is represented as pixels per cell.  Regarding groups with 
TGF-β supplementation, there is a trend toward increasing f-actin fiber density upon the addition 
of an external mechanical force.  FF+ samples yielded 1759.4 ± 319 pixels per cell, while the 
CS+ group led to the greatest f-actin fiber density of 3582.2 ± 832 pixels per cell (Figure 4-5).  
The data below reveals that the CS+ group was statistically significant when compared to CS- (p 
= 0.039) and its free float control, FF+ (p = 0.012).   
 
 
Figure 4-5:  F-actin quantification.  Data represented as mean ± SEM.  Blue bars indicate groups with 
TGF-β; purple bars indicate samples without TGF-β.  *Indicates a significant difference (p<0.05) when compared to 
the CS+ group.   
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4.3.2 Hematoxylin & Eosin 
While f-actin staining demonstrates cell alignment within the fibrin constructs, H&E allows the 
visualization of how compacted the cells are, as well as the location within the construct.  In 
these images, the nuclei are stained in purple and the fibrin gel is stained in pink.  As shown with 
f-actin statining, H&E confirms the alignment of cells in the direction of stretch.  Several 
samples also revealed that cells tend to reside at the edges of the constructs, as seen in the CS- 
panel in Figure 4-6.  Furthermore, cells in both FF groups demonstrated cell localization toward 
the center (marked ‘c’ in Figures 4-6 and 4-7) of the constructs.  
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Figure 4-6:  H&E staining of CS, SS and FF groups with (+) and without (-) TGF-beta.  Data shown is 
representative of all experiments.  Nuclei = purple; Fibrin = pink.  See Appendix C for images from all experiments.  
Arrows indicate the direction of stretch.  C indicates the center of the construct.  All images taken at 40x.   
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Figure 4-7:  H&E staining of FF+ group revealing cell localization in FF constructs.  Nuclei = purple; 
Fibrin = pink.  Left panel image taken at 10x.  Right panel image taken at 40x.   
 
4.4 QUALITATIVE PROTEIN EXPRESSION VIA IMMUNOHISTOCHEMISTRY 
4.4.1 α-SMA 
α-SMA is the earliest differentiation marker of SMCs.  CS+ and CS- groups both show abundant 
expression of this marker protein, while SS+/- groups reveal more sparse expression (see Figure 
4-8).  Neither of the FF+/- groups showed any positive staining for α-SMA. It must be noted, 
however, that this data is a result of a single experiment (n = 1), as immunostaining for this 
particular antibody in remaining experiments proved to be difficult due to reasons that will be 
discussed in Chapter 5.   
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Figure 4-8: Immunostaining with α-SMA for CS, SS and FF groups with (+) and without (-) TGF-
beta.  Green indicates positive α-SMA staining; nuclei are seen in blue.  See Appendix E for images from all 
experiments.  Data shown is representative of a single experiment.  All images taken at 40x.   
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4.4.2 Calponin 
Calponin is a mid-stage differentiation marker of SMCs.  As seen in Figure 4-9, both CS+ and 
CS- groups, as well as SS+, show some degree of positive staining for this antibody.  SS-, FF+ 
and FF- groups show no positive staining for calponin.  Green indicates positive calponin 
staining and nuclei are seen in blue.  Data seen in Figure 4-9 are representative images of n = 3.   
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Figure 4-9:  Immunostaining with calponin for CS, SS and FF groups with (+) and without (-) TGF-
beta.  Green indicates positive calponin staining; nuclei are seen in blue.  Data shown is representative of all 
experiments.  See Appendix F for images from all experiments.  All images taken at 40x.   
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4.4.3 MHC  
MHC is a marker of terminally differentiated SMCs.  As seen in Figure 4-10, none of the 
experimental groups showed positive staining for MHC.  The images in Figure 4-10 are 
representative images for all experiments.   
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Figure 4-10:  Immunostaining with MHC for CS, SS and FF groups with (+) and without (-) TGF-
beta.  Nuclei are seen in blue.  Data shown is representative of all experiments.  See Appendix G for images from all 
experiments.  All images taken at 40x.   
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4.5 COLLAGEN PRODUCTION 
4.5.1 Masson’s Trichrome 
Masson’s trichrome staining allows for visualization of collagen production.  Collagen staining 
(seen in blue in (Figure 4-11) indicates some degree of collagen production in most samples.  In 
CS+/- samples, collagen is predominantly located on the outer edges of the construct.  FF+/- 
samples, however, demonstrates a high degree of collagen production toward the center of the 
constructs.  This seems to draw a parallel with the cell localization described in Section 4.2.2, 
where cells were shown to be localized toward the center of FF+/- constructs.  Based on a 
qualitative assessment, both CS groups seem to have a higher degree of collagen present when 
compared to SS groups. 
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Figure 4-11:  Masson's trichrome staining for CS, SS and FF groups with (+) and without (-) TGF-
beta.  Data shown is representative of all experiments.  Blue = collagen; pink/red = fibrin; purple/black = nuclei.  
See Appendix H for images from all experiments.  All images taken at 40x.   
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4.5.2 Picrosirius Red  
Picrosirius red staining gives more detailed insight into the maturity of collagen fibers when 
compared to Masson’s trichrome staining.  Utilizing birefringence properties and polarized light 
microscopy, mature fibers (red and orange) may be distinguished from more immature collagen 
fibers (yellow and green).   
Figure 4-12 confirms the presence of collagen (to some degree) in all experimental 
groups.  The CS+ group appears to have the greatest amount of collagen, as seen in yellow in the 
CS+ panel.  The yellow fibers seen in the CS+ and CS- groups indicate the presence of immature 
collagen fibers.  The SS+ group indicates less mature collagen fibers when compared to CS+/- 
groups, as indicated by green fibers.  As with cell localization, PSR seems to reveal the presence 
of collagen at the outer edge of CS+/- and SS+/- groups (as indicated by ‘e’ in the panels in 
Figure 4-12), while FF+/- groups demonstrate more collagen production toward the center (as 
indicated by ‘c’).   
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Figure 4-12:  Picrosirius red staining for CS, SS and FF groups with (+) and without (-) TGF- beta.  
Data shown is representative of all experiments.  See Appendix I for images from all experiments.  The edge of the 
construct is denoted by an ‘e’; the center of the construct is denoted by a ‘c’.  Green and yellow fibers indicate more 
immature collagen while orange and red is denotes mature collagen fibers.  All images taken at 40x.   
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5.0  DISCUSSION 
Mechanical stimulation has been shown to regulate SMC differentiation in both smooth muscle 
cells and mesenchymal stem cells [93], suggesting that it may promote differentiation of 
BMMSCs toward a vascular smooth muscle cell phenotype.  Combined mechanical plus 
chemical stimulation has also proven to be potent regulators of SMC phenotype in in vitro 
bioreactor and culture systems [34, 37, 79].  To our knowledge, this is the first study that 
investigated the effects of combined mechanical and chemical stimulation of BMMSCs in a 3D 
fibrin matrix in an in vitro culture system.  Straining regimens consisted of 10% strain and 1 Hz, 
consistent with physiologic values as pertaining to the arterial system.  Biochemical 
supplementation with TGF-β was combined with mechanical stretching to elucidate any 
synergistic effects on cell viability, morphology, qualitative protein expression and collagen 
production.   
5.1 PROLIFERATION, VIABILITY AND MORPHOLOGY  
An MTT assay served as the most feasible cell viability assay for this work, as 3D models are 
notably difficult in regards to working with various assays and kits, which tend to be designed 
for 2D work or sections (see Section 5.4 on limitations).  Despite this, some trends still arise 
 66 
from the data on viability that parallel the findings of Nieponice et al [78].  When comparing no 
TGF-β groups (i.e. CS-, SS- and FF-) the SS- group yielded the greatest fold increase in cell 
number over day 0 (see Figure 4-3), which is consistent with the findings of Nieponice et al.  
When TGF-β is combined with mechanical stretch (the CS+ group), there is almost a 10-fold 
increase in cell number over day 0, yielding the greatest fold increase in cell number of all 
experimental groups.  This is suggestive of a synergistic effect, as TGF-β supplementation in SS 
and FF groups led to a decrease in cell proliferation.  However, because MTT is based on 
mitochondrial activity, measurement of cell proliferation may be an inaccurate portrayal, as 
mitochondrial activity may be different from cell to cell.  Therefore, this data may be viewed in 
the perspective of metabolic activity.  Because much of this work is relying on SMC protein 
production and expression, it may be valuable to consider metabolic activity as it relates to the 
production of ‘contractile machinery’.  As such, one may note that the CS+ group demonstrates 
the greatest amount of metabolic activity to produce the contractile machinery necessary for a 
fully differentiated SMC phenotype (see Figure 4-3).  This parallels the presence of SMC 
markers as seen via immunohistochemistry.  On the contrary, both FF groups yielded the lowest 
levels of metabolic activity, while both were also negative for SMC contractile markers.   
All groups of constructs compacted over the 6-day experimental period.  Morphology of 
BMMSCs in a 3D fibrin matrix was best-assessed using phalloidin staining for f-actin.  The 
presence of static stress or cyclic stretch altered the morphology of the BMMSCs when 
compared to stress- and strain-free controls (see Figure 4-4).  Both CS and SS groups align in 
the direction of strain, while FF groups exhibit random orientation.  This is contrary to related 
work done in 2D, where mechanical stimulation in 2D leads to perpendicular alignment relative 
to the direction of strain [74].  However, alignment of BMMSCs in the direction of strain in a 3D 
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environment in vitro parallels what is seen in vivo, further supporting the use of a 3D culture 
model for this work.   
Following qualitative analysis, f-actin was subsequently quantified using gray-scale 
thresholding in image analysis software and then normalized to numbers of cell nuclei. Statistical 
analysis revealed a significant difference between CS+ and CS-, suggesting a possible 
synergistic effect with mechanical and chemical stimulation.  When comparing all groups with 
TGF-β supplementation (i.e. FF+, SS+ and CS+), there is a trend toward increasing pixel density 
with increasing external mechanical stimuli (in other words, from FF+ to SS+ to CS+); see 
Figure 4-4.  Within cyclic stretch, static stress or free float groups, those with TGF-β 
supplementation led to greatest pixel density per cell when compared to counterpart groups with 
no TGF-β stimulation.    
Overall, there seems to be some subtle consistencies in trends with the MTT assay and f-
actin quantification.  Both of these endpoints demonstrate a trend toward increasing either 
proliferation or pixel density (MTT and f-actin quantification respectively) with increasing 
external mechanical stimulation, where CS+ groups demonstrate the greatest values for both 
endpoints.  This serves to confirm the idea that MTT can be represented in terms of contractile 
machinery production via metabolic activity, as there seems to be a correlation between f-actin 
and the MTT values.   
It is also worth mentioning the location of cells in the constructs following the 6-day 
experimental period, as it is assumed that BMMSCs are homogeneously suspended in the fibrin 
matrix at day 1 of the compaction period.  H&E staining allowed for better visualization of 
BMMSCs in sections when compared to phalloidin staining.  Cells seem to migrate toward the 
outer edges of the constructs in all CS+/- and SS+/- groups (see, e.g., Figure 4-7).  This may be 
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due to the ease of nutrient diffusion at the outer edge of the construct compared to the center line.  
On the other hand, the majority of the cells in FF+/- groups seem to migrate toward the center of 
the constructs.  It is speculated that this cell mobility toward the center of the construct may be a 
requirement for cell-mediated contraction of these fibrin gels. It is perhaps interesting to question 
why cells in FF groups aren’t migrating toward the edge for better nutrient diffusion, but rather 
toward the center.  This may be due the density of the fibrin in the free float conformation during 
compaction, and therefore the inability of cells to migrate toward the edges for better nutrient 
and O2 diffusion.   Compaction of the gels may also be forcing the cells toward the center of the 
constructs.  More work needs to be done to better understand these migratory mechanisms in the 
free float conformation during compaction. These cells could likely be dead at the end of the 
experimental period, perhaps also accounting for the low values seen in the MTT assay for the 
FF+/- groups (see Figure 4-1).  The location of cells in all groups also seems to correlate well 
with the location of collagen, and this will be the focus of Section 5.2.   
5.2 COLLAGEN PRODUCTION 
TGF-β and mechanical strain alone have been shown to play a role in collagen production in 
various applications [106, 115].  This suggests that TGF-β with mechanical stimulation may also 
promote collagen production in BMMSC-laden constructs used in the 3D model.  As such, 
Masson’s Trichrome and picrsosirius red staining were completed as an assessment of qualitative 
collagen production in the fibrin gel constructs.   
 The CS+ group appears to have the greatest amounts of collagen when compared to the 
remaining groups, as seen by Masson’s Trichrome staining for collagen.  Other experimental 
 69 
groups, namely CS-, SS+ and SS-, also show some degree of collagen production.  The collagen 
seems to be localized at the edges of the constructs in both CS+/- and SS+/- groups, which is 
consistent with the localization of cells (see Section 5.1).  Because the cells are producing and 
laying down the ECM, it seems logical that the location of collagen matches that of the cells in 
the fibrin matrix.   
 Unlike the CS+/- and SS+/- groups, the FF+/- groups show collagen production toward 
the center of the constructs, which is also consistent with the cell localization (see Figures 4-6 
and 4-11).  Perhaps surprising is that there is some collagen production in these experimental 
groups, which are not subjected to any external mechanical strain.   TGF-β seems to play a role 
in producing ECM in FF+ groups when compared to FF- (see Figure 4-11).   
 Picrosirius red staining corroborates the findings seen with collagen production via 
Masson’s Trichrome staining, while giving more detailed information on the maturity of the 
collagen that is present.  The CS+ group reveals the most mature collagen fibers present (as seen 
in yellow in Figure 4-12).  The localization of collagen toward the center of the constructs in the 
FF+/- groups is also apparent here.   
 Overall, collagen production seems to be regulated by both mechanical and chemical 
stimulation, and when combined it seems to enhance collagen production by BMMSCs in a 3D 
fibrin matrix.   
5.3 QUALITATIVE PROTEIN EXPRESSION  
Since the main objective of this work is to explore factors in the differentiation of BMMSCs 
toward an SMC phenotype via exogenous mechanical and chemical stimuli, 
 70 
immunohistochemistry was used to determine the degree of differentiation of SMCs.  As noted 
earlier, SMCs are plastic cells whose phenotype exists as a spectrum between a synthetic and 
contractile phenotype.  As such, experimental groups were evaluated for qualitative protein 
production and phenotype via immunostaining.  Experimental groups were stained for α-SMA, 
calponin, and MHC as early, mid-stage, and terminally-differentiated SMC markers respectively.   
Immunostaining for α-SMA gave highly variable results.  The data shown in Figure 4-6 
is most consistent with the findings from both prior work [78] as well as the immunostaining for 
calponin (see Figure 4-7). However, this finding was for only one out of five experiments.  
There are several potential reasons for this variability.  Because fibrin constructs are extremely 
small (180 μl when originally fabricated) they cannot be cryosectioned nor paraffin-embedded 
for immunostaining purposes. This was the volume limit to utilize the tissue train system. 
Therefore, the permeabilization period during immunostaining had to be adjusted to account for 
this.  It is speculated that α-SMA antibody may not have been small enough to reach the cells 
and bind to the α-SMA proteins within the cell.  However, because there is positive calponin 
expression for CS+/- and SS+ groups (Figure 4-9), it was expected that α-SMA expression 
would also be evident for these groups, due to the hierarchical nature of protein expression for 
mature SMCs.  It was therefore concluded that there may have been an issue with the α-SMA 
antibody, the permeabilization time, or both.  A suitable positive control is necessary to 
determine these parameters. 
As indicated above, some positive calponin expression was evident in CS+/- and SS+ 
groups (Figure 4-9).  This indicates that some of BMMSCs are differentiating toward an SMC 
phenotype in response to TGF-β, mechanical stimuli, or both.  None of the groups showed any 
positive staining for the terminally-differentiated SMC marker, MHC (Figure 4-10).  This may 
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be due to the short experimental period.  A longer experimental time-frame may have allowed 
for MHC protein synthesis.  Future work including SMC gene expression may determine if 
MHC is being upregulated during this experimental timeframe.   
 
5.4 LIMITATIONS 
There are several limitations to this work that will be discussed in this section.  While the chosen 
model allows for the understanding of the effects mechanical and chemical stimulation in 3D, it 
is difficult to process for various quantitative endpoints due to the small size of each construct, 
and therefore the lower cell number and, consequently, low SMC protein and ECM production.   
Despite the ability to better mimic physiologic conditions using a 3D model, it is often 
more tedious and difficult to work with than 2D models.  As mentioned previously, samples 
could not be cryosectioned for immunostaining, and therefore the permeabilization time in 
whole-mounted samples had to be tailored such that the antibodies could diffuse into the cell 
without compromising the cell membrane.  This proved to be difficult as seen with the α-SMA 
staining.   
The quality antibodies used in this work may have been evaluated using an appropriate 
positive control.  There were several possibilities in choosing a positive control.  One option was 
a cryosection of a rat aorta.  However, because this would not mimic the density or thickness of 
the fibrin gel, this was not considered to be appropriate.  Permeabilization of rat aorta would not 
be consistent with that of cells embedded in fibrin.  Fibrin incorporated with SMCs was also 
considered as a positive control.  This was also inappropriate because SMCs dedifferentiate once 
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removed from a mechanical environment.  Also, the density of fibrin embedded with BMMSCs 
increased through the duration of the experiment, making a positive control with SMCs at t0 also 
inappropriate.   
An appropriate cell counting assay was difficult to employ with our model.  Several 
attempts have been made at digesting the constructs to utilize 2D cell counting kits, such as 
CyQUANTTM.  However, because several of these assays rely on flurochromes binding to DNA 
and measuring the absorbance, fragments of fibrin following digestion often interfered with the 
absorbance readings, likely giving inaccurate values.   
As it was noted that there was collagen production in samples being made of only fibrin 
gel and BMMSCs at day 0 of the experimental period, it may have been more interesting to make 
quantitative measures on collagen production to determine more concrete differences between 
experimental groups.  Attempts have been made to do this via a hydroxyproline assay.  However, 
because the 3D constructs are extremely small (each with a volume of 180 μl) the amount of 
detectable collagen was at the low end of the detectable region of the standard curve and 
therefore could not be accurately measured.   
Lastly, confirmatory work including gene expression and western blotting would be ideal 
to confirm the qualitative protein expression via immunohistochemistry.  However, the size of 
the constructs again proves to be a limitation, as the fewer number of cells leads to lower 
expression of mRNA and lesser protein production for these purposes, respectively.  Increasing 
the concentration of cells in the fibrin gel was attempted to overcome this limitation.  However, 
this did not yield an adequate number of cells per group for RNA analysis purposes.  Pooling 
samples together from all experiments may have been a solution to this limitation, however this 
would create a sample size of one.  
 73 
6.0  FUTURE WORK  
This work has several elements that may be interesting to explore further in future work.  
BMMSCs are ideal for the reasons described in Section 1.2.3, however other cell types are also 
capable of responding to mechanical and/or chemical stimulation.  As cell sourcing is one the 
major components in creating the ideal TEVG, the perfect cellular component for this application 
is still a missing puzzle piece.  The experimental time frame may also be manipulated to 
determine the optimal time in which SMC differentiation is the greatest.  A longer experimental 
period may have yielded greater protein expression and ECM production, and further work may 
investigate the time required to produce SMC contractile proteins that are necessary for a fully 
differentiated SMC phenotype.   
In regards to chemical stimulation, TGF-β is not the only growth factor known to 
promote SMC differentiation.  It would be therefore interesting to look at a cadre of various 
growth factors to determine any synergistic effects with other growth factors, either individually 
or in combination, along with mechanical stimulation.   
SMA and calponin expression may have been semi-quantified just as f-actin was using 
gray-scale thresholding.  This would allow for a more direct comparison between groups.  This 
may be done in future work to generate more quantitative data and allow for a statistical analysis 
between experimental groups.   
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Fibrin is not the only scaffold material that could be used for this 3D model application.  
Others have used collagen, collagen/fibrin mixtures, and polymers to act as an appropriate 
scaffold to induce mechanical stimulation in 3D [22].   
A major component of this work that was unfortunately beyond the scope of this current 
project was an evaluation of gene expression.  An assessment of gene expression would allow for 
detection of more subtle differences between experimental groups, while gaining insight as to 
how BMMSCs are responding to mechanical and chemical stimuli via up- or down-regulation of 
SMC-related, apoptotic-related, and ECM-related gene expression.   
Western blotting and subsequent protein expression would allow for more quantitative 
protein analysis, while also confirming findings from SMC gene expression.  This would also 
allow for the detection of proteins not seen using immunohistochemistry.   
Finally, future work will need to assess functionality of differentiated BMMSCs via the 
addition of exogenous contractile agents.  This is the true test of a fully differentiated and 
functional SMC, and is a distinguishing characteristic that often goes under-emphasized in much 
of the related work in tissue engineering and regenerative medicine applications.   
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7.0  CONCLUSIONS 
Previously published work has demonstrated that BMMSCs are capable of differentiating into 
several different lineages.  This has motivated us to explore whether BMMSCs subjected to the 
appropriate milieu of mechanical stimuli and growth factors will differentiate toward an SMC 
phenotype.  Here, we investigated the effect of mechanical and chemical stimuli on BMMSCs 
suspended in a 3D fibrin matrix to determine the capacity in which these cells are capable of 
differentiation.  Overall, the purpose of this project was to further investigate the effects of both 
mechanical and chemical stimulation, and better understand how these stimuli may act 
synergistically to promote a SMC phenotype relevant to regenerative medicine applications.   
The work presented in this thesis suggests that BMMSCs are capable of differentiating 
into an SMC phenotype, however there is much more work to be done to better elucidate the 
mechanisms of differentiation, and how mechanical and biochemical stimuli are working 
together to produce a synergistic effect.  As demonstrated through qualitative protein analysis, 
BMMSCs respond to cyclic stretch with and without TGF-β, as well as static stress in the 
presence of TGF-β, as evidenced through calponin expression.  MTT and f-actin quantification, 
when taken together, may indicate an increase in the production of ‘contractile machinery’ 
intrinsic to a fully differentiated SMC.  Lastly, TGF-β stimulation combined with mechanical 
strain seems to lead to an increase in collagen production.  More work needs to better elucidate 
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the diffusion of TGF-β into these fibrin constructs in order to optimize its effects on SMC 
differentiation.   
In conclusion, this work has provided significant information on the therapeutic potential 
of BMMSCs toward small diameter graft applications, as well as all other regenerative medicine 
applications requiring SMCs as a cellular replacement.  The results obtained from this project 
underscore the usefulness of BMMSCs in the realm of tissue engineering and related fields.  This 
work continues to move forward in Dr. Vorp’s laboratory as researchers are trying to better 
understand how various cell types respond to mechanical strain in 2D and 3D models.  Other 
work is moving toward in vivo models where we can better understand how this cell type 
integrates into the host tissue, and how the local environment influences the cell phenotype. 
While the ‘holy grail’ of tissue engineering is still widely sought after, we are perhaps 
one step further in understanding how the mechanical and chemical environment may work 
together to influence cell phenotype toward regenerative medicine therapies.    
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APPENDIX A 
PREPARATION OF FIBRIN GEL TISSUE TRAIN CONSTRUCTS 
Tissue train constructs for all experimental groups were prepared in accordance with the 
following protocol: 
Each ‘batch’ of fibrin solution was prepared so as to create 3 ml of working solution, 
which was sufficient to fabricate 12 tissue train constructs.  Because there is a limited amount of 
time to work with the fibrinogen/thrombin suspension as an enzymatic reaction is taking place 
(i.e. the clotting cascade), a small volume was chosen for ease of handling.  To make 3 ml of 
final solution, 2 ml of fibrinogen with εACA solution (5 mg/ml of fibrinogen + 1 mg/ml εACA 
in serum-free a-MEM) was combined with a cell suspension of 6 x 106 cells/ml in 0.5 ml, to 
yield a final concentration of 1 x 106 cells/ml.  The fibrinogen solution was prepared first and set 
aside on ice, while cell trypsinization and counting was taking place.  Once the appropriate 
concentration of cells was achieved, 0.5 ml of the cell suspension was added to the fibrinogen 
solution as described above.  The thrombin solution was prepared separately by combining 0.5 
ml of serum-free α−MEM and 1 UI of thrombin (10 μl) in a sterile eppendorf tube.  For samples 
receiving TGF-β supplementation, 3 μl of 10 μg/ml TGF-β solution was added to achieve a final 
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concentration of 10 ng/ml in the constructs.  Once all solutions were prepared, they were kept on 
ice while during device setup.   
Tissue train posts, seen below in Figure A-1 were attached to the baseplate.  Tissue train 
plates were then placed on top of the tissue train posts, while maintaining a tight seal so as to not 
cause a pressure leak in the system.  A vacuum line was then connected from the housevac to the 
baseplate with tubing.  The vacuum was then turned on, allowing the flexible membrane 
substrate to be pulled into the tissue train troughs of the posts, thereby creating a 3D depression 
in which to add the fibrinogen/thrombin solution for fibrin gel fabrication.   
 
 
Figure A-1:  Tissue train post sitting below tissue train plates.  Figure adapted from 
www.fleccellint.com.   
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Once the device setup was finalized, the thrombin solution was combined with the 
fibrinogen/cell suspension and the conical tubes were inverted several times for mixing to ensure 
homogeneous distribution of cells in the solution.  The solution then had to be pipetted quickly 
as the gel would begin to form within approximately 30 seconds.  180 μl of the fibrin solution 
was added to the tissue train troughs until 1 batch was completely used.  Once this process was 
completed, the baseplates were transferred to an incubator during the gelation process.  After 30 
minutes of gelation, 5 ml of media were added to tissue train plates (i.e. CS and SS groups) and 2 
ml of media were added to 12-well plates (FF groups).  For samples receiving TGF-β, a separate 
solution of media was prepared with TGF-β to achieve a final concentration of 10 ng/ml of TGF-
β in the media, and media was added as described above.   
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APPENDIX B 
OPTIMIZATION OF FIBRIN DEGRADATION FOR FACS 
Fluorescence activated cell sorting (FACS) was considered for this work in an effort to quantify 
SMC protein expression.  However, this raised 2 significant questions:  1. How can the cells be 
recovered from the fibrin matrix following the experiment?  2.  Once the cells have been 
recovered, how can antibodies for FACS work on intracellular SMC proteins of interest?  To 
answer the first question, a fibrin digestion protocol obtained from the laboratory of Kristen 
Billiar was manipulated and tested to enzymatically digest the fibrin to obtain the greatest 
percentage of the original cell number.   
To digest fibrin gels, media was removed from the wells, and constructs were transferred 
to 15 ml conical tubes.  10 ml of 50 mM Tris/Calcium Acetate (Sigma-Aldrich, St. Louis, MO) 
buffer was added to the 15 ml conical tube, followed by the addition of trypsin (Invitrogen, 
without EDTA) to create a final concentration of 0.05%.  0.02 g of collagenase type II 
(Washington Biotech) was added to this solution to create a 2 mg/ml concentration.  Conical 
tubes were then placed in heat blocks at 37 C, and were shaken vigorously every 1 – 2 minutes.  
The fibrin gels were dissolved within 30 – 45 minutes.  The remaining digest solution was 
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centrifuged, resuspended in complete α-MEM, and replated on T25 flasks.  24 hours following 
the digestion, cells were viewed under a bright field microscope.  See Figure B-1 below.    
 
 
 
 
Figure B-1:  Recovered BMMSCs from fibrin digestion following replating after 24 hours.  Image 
taken at 20x. 
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APPENDIX C 
H&E STAINING 
H&E staining seen in Figures C-1 – C-5 are images from experiments 1 – 5, respectively.   
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Figure C-1:  H&E staining for Experiment 1.  Nuclei = purple; Fibrin = pink.  All images taken at 40x.    
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Figure C-2:  H&E staining for experiment 2. Nuclei = purple; Fibrin = pink.  FF+ group lost during 
experiment.  All images taken at 40x.    
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Figure C-3:  H&E staining for Experiment 3.  Nuclei = purple; Fibrin = pink.  All images taken at 40x.    
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Figure C-4:  H&E staining for Experiment 4.  Nuclei = purple; Fibrin = pink.  All images taken at 40x.    
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Figure C-5:  H&E staining for Experiment 5.  Nuclei = purple; Fibrin = pink.  SS+ group was lost during 
the experiment.  All images taken at 40x.    
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APPENDIX D 
F-ACTIN 
Phalloidin staining seen in Figures D-1 – D-5 are resulting images from experiments 1 – 5, 
respectively.   
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Figure D-1:  Phalloidin staining for Experiment 1.  Nuclei = blue; F-actin fibers= green.  All images 
taken at 40x.    
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Figure D-2:  Phalloidin staining for Experiment 2.  Nuclei = blue; F-actin fibers= green.  FF+ group lost 
during the experiment.  All images taken at 40x.    
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Figure D-3:  Phalloidin staining for Experiment 3.  Nuclei = blue; F-actin fibers= green.  SS-, FF+ and 
FF- files became corrupt during the image acquisition process.  All images taken at 40x.    
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Figure D-4:  Phalloidin staining for Experiment 4.  Nuclei = blue; F-actin fibers= green.  All images 
taken at 40x.    
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Figure D-5:  Phalloidin staining for Experiment 5.  Nuclei = blue; F-actin fibers= green.  FF- group lost 
during the experiment.  All images taken at 40x.    
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APPENDIX E 
Α-SMA 
 
α-SMA staining seen in Figures E-1 and E-2 are images from experiments 1 and 5, 
respectively.  Data for experiment 2 is seen in Section 4.4.1.  For experiments 1,2 and 5, the α-
SMA antibody from Sigma was utilized, while for experiments 3 and 4, the Chemicon α-SMA 
antibody was used (see Table 3-1).     Experiments 3 and 4 were all negative for α-SMA upon 
inspection, and therefore were not imaged.   
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Figure E-1:  α-SMA staining for Experiment 1.  Nuclei = blue; α-SMA = green.  All images taken at 
40x.    
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Figure E-2:  α-SMA staining for Experiment 5.  Nuclei = blue; α-SMA = green.  FF- group lost during 
the experiment.  All images taken at 40x.    
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APPENDIX F 
CALPONIN 
Calponin staining seen in Figures F-1 – F-5 are images from experiments 1 – 5, respectively.   
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Figure F-1:  Calponin staining for Experiment 1.  Nuclei = blue; calponin = green.  All images taken at 
40x.    
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Figure F-2:  Calponin staining for Experiment 2.  Nuclei = blue; calponin = green.  FF+ group lost 
during the experiment.  All images taken at 40x.    
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Figure F-3:  Calponin staining for Experiment 3.  Nuclei = blue; calponin = green.  FF+/- groups were 
negative for calponin and were not imaged in the interest of time.  All images taken at 40x.    
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Figure F-4:  Calponin staining for Experiment 4.  Nuclei = blue; calponin = green.  FF+/- groups were 
negative for calponin and were not imaged in the interest of time.  All images taken at 40x.    
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Figure F-5:  Calponin staining for Experiment 5.  Nuclei = blue; calponin = green.  All images taken at 
40x.    
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APPENDIX G 
MHC 
MHC staining seen in Figures G-1 – G-5 are images from experiments 1 – 5, respectively.   
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Figure G-1:  MHC staining for Experiment 1.  Nuclei = blue; MHC = green.  Images taken at 40x.    
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Figure G-2:  MHC staining for Experiment 2.  Nuclei = blue; MHC = green.  FF+ group lost during the 
experiment.  All images taken at 40x.    
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Figure G-3:  MHC staining for Experiment 3.  Nuclei = blue; MHC = green.  SS+/- and FF+/- groups 
were negative for MHC and were not imaged in the interest of time.  All images taken at 40x.    
 
 
 
 
 
Figure G-4:  MHC staining for Experiment 4.  Nuclei = blue; MHC = green.  FF+/- groups were 
negative for MHC and were not imaged in the interest of time.  All images taken at 40x.    
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Figure G-5:  MHC staining for Experiment 5.  Nuclei = blue; MHC = green.  All images taken at 40x.    
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APPENDIX H 
MASSON’S TRICHROME  
Masson’s Trichrome staining seen in Figures H-1 – H-5 are images from experiments 1 – 5, 
respectively.   
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Figure H-1:  MT staining for experiment 1. Nuclei = purple; fibrin = pink/purple; collagen = blue.  All 
images taken at 40x.    
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Figure H-2:  MT staining for experiment 1. Nuclei = purple; fibrin = pink/purple; collagen = blue.  FF- 
group lost during the experiment.  All images taken at 40x.    
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Figure H-3:  MT staining for experiment 3. Nuclei = purple; fibrin = pink/purple; collagen = blue.  All 
images taken at 40x.    
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Figure H-4:  MT staining for experiment 4. Nuclei = purple; fibrin = pink/purple; collagen = blue.  FF- 
group imaged at 60x.  All other images taken at 40x.    
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Figure H-5:  MT staining for experiment 5. Nuclei = purple; fibrin = pink/purple; collagen = blue.  SS+ 
group lost during the experiment.  CS+ group imaged at 60x.  All other images taken at 40x.    
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APPENDIX I 
PICROSIRIUS RED 
PSR staining seen in Figures I-1 – I-5 are images from experiments 1 – 5, respectively.   
 
 
Figure I-1:  PSR staining for experiment 1.  Green/yellow fibers indicate more immature collagen; 
orange/red fibers indicate more mature collagen.  CS+/- groups were not used for imaging due to artifacts from the 
sectioning process. All images taken at 40x.    
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Figure I-2:  PSR staining for experiment 2.  Green/yellow fibers indicate more immature collagen; 
orange/red fibers indicate more mature collagen.  FF+ group lost during the experiment. All images taken at 40x.    
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Figure I-3:  PSR staining for experiment 3.  Green/yellow fibers indicate more immature collagen; 
orange/red fibers indicate more mature collagen.  All images taken at 40x.    
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Figure I-4:  PSR staining for experiment 4.  Green/yellow fibers indicate more immature collagen; 
orange/red fibers indicate more mature collagen.  All images taken at 40x.    
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Figure I-5:  PSR staining for experiment 5.  Green/yellow fibers indicate more immature collagen; 
orange/red fibers indicate more mature collagen.  SS+ group lost during the experiment.  All images taken at 40x.    
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